Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report

BACKGROUND: Dipeptidyl peptidase 4 inhibitor (DPP4i) is an effective medicine for type 2 diabetes mellitus (T2DM). Some articles reported DPP4i improves insulin secretion and insulin resistance. However, these effects are not well established by glucose clamp test and test meal in Japanese. We inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Okura, Tsuyoshi, Fujioka, Yohei, Nakamura, Risa, Ito, Yuichi, Kitao, Sonoko, Anno, Mari, Matsumoto, Kazuhisa, Shoji, Kyoko, Okura, Hiroko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171964/
https://www.ncbi.nlm.nih.gov/pubmed/35672759
http://dx.doi.org/10.1186/s13098-022-00850-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171964/
https://www.ncbi.nlm.nih.gov/pubmed/35672759
http://dx.doi.org/10.1186/s13098-022-00850-9

Ejemplares similares